GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Cash Flow for Lease Financing

Rising Biosciences (Rising Biosciences) Cash Flow for Lease Financing : $ Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Cash Flow for Lease Financing?

Rising Biosciences's Cash Flow for Lease Financing for the three months ended in . 20 was $0.00 Mil. Rising Biosciences does not have enough years/quarters to calculate the Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in . 20.

Compared with last quarter ($0.00 Mil in . 20 ), Rising Biosciences's Cash Flow for Lease Financing remained the same in . 20 ($0.00 Mil).


Rising Biosciences Cash Flow for Lease Financing Historical Data

The historical data trend for Rising Biosciences's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Cash Flow for Lease Financing Chart

Rising Biosciences Annual Data
Trend
Cash Flow for Lease Financing

Rising Biosciences Quarterly Data
Cash Flow for Lease Financing

Rising Biosciences Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.



Rising Biosciences Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

Rising Biosciences Set To Acquire All Assets from PAO Group

By Marketwired Marketwired 11-07-2018

PAOG Officially Appoints Karl Riedel as New CEO and President

By Marketwired Marketwired 02-11-2019